Metrics to compare | 4892 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship4892PeersSector | |
|---|---|---|---|---|
P/E Ratio | −8.6x | 10.5x | −0.4x | |
PEG Ratio | −0.46 | 0.01 | 0.00 | |
Price/Book | 2.6x | 1.3x | 2.6x | |
Price / LTM Sales | 22.3x | 1.3x | 3.1x | |
Upside (Analyst Target) | - | 6.7% | 57.4% | |
Fair Value Upside | Unlock | 12.4% | 7.7% | Unlock |
Cyfuse Biomedical K.K. develops, manufactures, and sells regenerative medicine-related products in Japan, Europe, and the United States. The company offers the Bio 3D Printer for use in the regeneration of various tissues and organs, such as cartilage and bone, blood vessels, and nerves; regenova, a 3D software that creates 3D data where spheroids shall be mounted; and S-PIKE that develops 3D-structures from cells. It also provides the Human 3D Mini-Liver, an in vitro MASH model that recapitulates human liver functions and predicts efficacy of drugs. Cyfuse Biomedical K.K. was incorporated in 2010 and is headquartered in Minato, Japan.